Enhanced insulin-hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom

Molecular and Cellular Biochemistry

Volumn 306, Issue 1-2, 2007, Pages 105-113

  Preuss, H Garry ^a   Echard, Bobby ^a   Bagchi, Debasis ^b   Perricone, Nicholas V ^c   Zhuang, Cun ^d  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d Maitake Products Inc   (United States)

Author keywords

Insulin resistance; Insulin sensitivity; Maitake; Natural products; SX fraction

Indexed keywords

GLUCOSE; GLYCOPROTEIN; GRIFOLA FRONDOSA EXTRACT; INSULIN; NATURAL PRODUCT; PIOGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FLUID INTAKE; FOOD INTAKE; GLUCOSE TOLERANCE TEST; GRIFOLA FRONDOSA; HYPOGLYCEMIA; INSULIN SENSITIVITY; LOW DRUG DOSE; MUSHROOM; NONHUMAN; RANDOMIZATION; RAT; SINGLE DRUG DOSE; SPONTANEOUSLY HYPERTENSIVE RAT;

AGARICALES; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; FUNGAL PROTEINS; GLUCOSE TOLERANCE TEST; GLYCOPROTEINS; HYPOGLYCEMIC AGENTS; INSULIN; PLANT EXTRACTS; RATS; RATS, INBRED SHR; THIAZOLIDINEDIONES;

BASIDIOMYCOTA; GRIFOLA FRONDOSA; RATTUS;

EID: 35548970239     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9559-6     Document Type: Article

References (38)

1. Preuss HG (1997) Effects of glucose/insulin perturbations on aging and chronic disorders of aging: The evidence. J Am Coll Nutr 16:397-403
2. Preuss HG, Bagchi D, Clouatre D (2001) Insulin resistance; a factor in aging. In: Ghen MJ, Corso N, Joiner-Bey H, Klatz R, Dratz A (eds) The advanced guide to longevity medicine. Ghen, Landrum, SC, pp 239-250
3. Preuss HG, Bagchi D (2002) Nutritional therapy of impaired glucose tolerance and diabetes mellitus. In: Felix B (ed) Nutritional aspects and clinical management of chronic disorders and diseases. CRC Press, Boca Raton FL, pp 69-91
4. McCay C, Crowell M, Maynard L (1935) The effect of retarded growth upon the length of life and upon ultimate body size. J Nutr 10:63-79
5. Yu BP, Masoro EJ, Murata I, Bertrand HA, Lynd FT (1982) Lifespan study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass, and disease. J Gerontol 37:130-141
6. Hopkin K (1995) Aging in focus. Caloric restriction may put the brakes on aging. J NIH Res 7:47-50
7. Roth GS, Ingram DK, Lane MA (2001) Caloric restriction in primates and relevance to humans. Ann NY Acad Sci 928:305-315
8. Masoro EJ, McCarter RJM, Katz MS, McMahan CA (1992) Dietary restriction alters characteristics of glucose fuel use. J Gerontol 47:B202-B208
9. Preuss HG (1998) Aging: Relationship to insulin resistance. Maturity: Canada 1:12-14
10. Dilman VM, Anisimov VN (1980) Effect of treatment with phenformin, dyphenylhydantoin, or L-DOPA on lifespan and tumor incidence in C3H/Sn mice. Gerontology 26:241-245
11. Preuss HG, Montamarry S, Echard B, Scheckenbach R, Bagchi D (2001) Long-term effects of chromium, grape seed extract, and zinc on various metabolic parameters of rats. Mol Cell Biochem 223:95-102
12. Preuss HG, Bagchi D, Bagchi M (2002) Protective effect of a novel niacin-bound chromium complex, a grape seed proanthocyanidin extract on advancing age and various aspects of syndrome X. In: Das DK, Ursini F (eds) Alcohol and wine in health and disease. Annals NY Acad Sci 957:250-259
13. Talpur N, Echard B, Yasmin D, Bagchi D, Preuss HG (2003) Effects of niacin-bound chromium, maitake mushroom fraction SX and a novel (-)-hydroxycitric acid extract on the metabolic syndrome in aged diabetic Zucker Fatty Rats. Molec Cell Biochem 252:369-377
14. Anisimov VN, Semenchenko AV, Yashin AI (2003) Insulin and longevity: antidiabetic biguanides as geroprotectors. Biogerontology 4:297-307
15. Lane MA, Ingram DK, Roth GS (2002) The serious search for an anti-aging pill. Sci Am 287:36-41
16. Ingram DK, Anson RM, de Cabo R, Mamczarz J, Zhu M, Mattison J, Lane MA, Roth GS (2004) Development of calorie restriction mimetics as a prolongevity strategy. Ann NY Acad Sci 1019:412-423
17. Roth GS, Lane MA, Ingram DK (2005) Caloric restriction mimetics: The next phase. Ann NY Acad Sci 1057:365-371
18. Campbell IW (1985) Metformin and the sulphonylureas: The comparative risk. Horm Metab Res Suppl. 15:105-111
19. Gale EA (2001) Lessons from the glitazones: A story of drug development. Lancet 357:1870-1875
20. Isley WL (2003) Hepatotoxicity of thiazolidinediones. Expert Opin Drug Saf 2:581-586
21. Mallick S (2004) Metformin induced acute pancreatitis precipitated by renal failure. Postgrad Med J 80:239-240
22. Spiller HA, Sawyer TS (2006) Toxicology of oral antidiabetic medications. Am J Health Syst Pharm 63:929-938
23. Masubuchi Y (2006) Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: A review. Drug Metab Pharmacokinet 21:347-356
24. Langenfeld MR, Forst T, Hohberg C (2005) Pioglitazone decreases carotid intima-media thickness independent of glycemic control in patients with type 2 diabetes mellitus. Circulation 111:2525-2531
25. Jiang G, Zhang BB (2005) Modulation of insulin signaling by insulin sensitizers. Biochem Soc Trans 33:358-361
26. Lawrence JM, Reckless JB (2000) Pioglitazone. Int J Clin Pract 54:614-618
27. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE (1966) Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 50:219-244
28. Bunag RD (1973) Validation in awake rats of a tail-cuff method measuring systolic pressure. J Appl Physiol 34:279-282
29. Dunnett C (1955) A multiple comparison procedure for comparing several treatments with control. J Am Statis Assoc 50:1096-1121
30. Preuss MB, Preuss HG (1980) Effects of sucrose on the blood pressure of various strains of Wistar rats. Lab Invest 43:101-107
31. Chang S-L, Lin K-J, Lin R-T, Hung P-H, Lin J-G, Cheng J-T (2006) Enhanced insulin sensitivity using electroacupuncture on bilateral Zusanli acupoints (ST 36) in rats. Life Sci 79:967-971
32. Williams CA, Shih MF, Taberner PV (2000) Effect of acute and sub-chronic administration of the imidazoline compound S 22068 on in vivo glucose and insulin responses in normal lean CBA/Ca mice. Gen Pharmacol 34:183-191
33. Williams CA, Shih MF, Taberner PV (1999) A simple acute in vivo comparative test for sensitivity to insulin in the mouse. Horm Metab Res 31:580-582
34. Kim DS, Kim TW, Kang JS (2004) Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats. J Trace Elem Med Biol 17:243-247
35. Reaven GM, Hoffman BB (1987) A role for insulin in the aetiology and course of hypertension? Lancet ii:435-436
36. Preuss HG, Gondal JA, Bustos E, Bushehri N, Lieberman S, Bryden NA, Polansky MM, Anderson RA (1995) Effect of chromium and guar on sugar-induced hypertension in rats. Clin Neph 44:170-177
37. Preuss HG, Grojec P, Lieberman S, Anderson RA (1997) Effects of different chromium compounds on sugar-induced hypertension. Clin Nephrol 47:325-330
38. Preuss HG, Anderson RA, Gondal J (1998) Comparative effects of chromium, vanadium, and Gymnema Sylvestre on sugar-induced blood pressure elevations in SHR. J Amer Coll Nutr 17:116-123